Gujaratís other calling card

Gujaratís other calling card

Whether it is female infanticide, education or health indicators, Modiís Gujarat...
Safe assets

Safe assets

The asset disclosures for the 2014 Lok Sabha elections...

Sun Pharma shares falls on competition from Glenmark drug

Comments 0
'Leading brand in this segment is Taro's Topicort, which had annual sales of $50 million.' (AP) 'Leading brand in this segment is Taro's Topicort, which had annual sales of $50 million.' (AP)
Summary'Leading brand in this segment is Taro's Topicort, which had annual sales of $50 million.'

Shares in India's Sun Pharmaceuticals Industries fall 1 percent as the US Food and Drug Administration approval for Glenmark's Desoximetasone ointment is seen negative for the former's unit, Taro Pharmaceutical Industries Ltd.

Analysts tracking the sector say the leading brand in this segment is Taro's Topicort, which had annual sales of $50 million.

Also, Citigroup in a report says while Taro has also lost market share in its largest product Nystatin/Triam combo, it could see more competition in some of its other products

Ads by Google

More from Markets

Reader´s Comments
| Post a Comment
Please Wait while comments are loading...